Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
AMRI, a leading global contract research and manufacturing organization, announced today the appointment of Ian Shott as President of AMRI Europe, reporting to Thomas D’Ambra, Ph.D., chairman, president and CEO. In this newly created role, Mr. Shott ...
read more
Tuesday, February 07, 2017
AMRI has entered an alliance with Bruker Daltonics and HighRes Biosolutions to develop new applications for using high throughput mass spectrometry (MS) for drug discovery.
read more
Thursday, February 04, 2016
AMRI has announced that Anthony J. Maddaluna, Executive Vice President of Pfizer Inc. and President of Pfizer Global Supply, has been elected to the AMRI Board of Directors, effective as of February 4, 2016.
read more
AMRI announced Paul Feuerman has joined the company as senior vice president, general counsel and head of business development.
read more
AMRI has hired Louis Yu, Ph.D., to fill the newly created position of senior vice president of quality and compliance. Dr. Yu will report to William S. Marth, AMRI's president and CEO. Dr. Yu will oversee all aspects of quality and cGMP compliance at...
read more
Wednesday, February 21, 2018
AMRI announced the appointment of Anthony Mattacchione as senior vice president and chief financial officer, effective April 2, 2018.
read more
Thursday, September 21, 2017
In response to evolving industry guidelines, AMRI has assembled a medical device solutions team to help customers navigate the regulatory complexities of developing and testing medical device products.
read more
Thursday, October 03, 2013
AMRI today announced that its wholly owned subsidiary, Albany Molecular Research (UK) Ltd., located in Holywell, Wales, United Kingdom, has been awarded a seven-year contract for the development and manufacture of an active ingredient under clinical...
read more
Albany Molecular Research, a contract research development and manufacturing organization, announced that it is changing its name to Curia, effective July 12, 2021. The new name reinforces the company’s strategic positioning as an end-to-end global ...
read more
Wednesday, April 16, 2014
AMRI (NASDAQ: AMRI) today announced that it
has completed the previously announced acquisition of Cedarburg Phar-
maceuticals, Inc.
read more
AMRI announced that it has completed the acquisition of Prime European Therapeuticals S.p.A., also known as "Euticals", a privately-held company headquartered in Lodi, Italy, specializing in custom synthesis and the manufacture of active ...
read more
AMRI announced the company’s manufacturing facility in Rensselaer, NY has been designated “Industry Leader” as part of its re-certification under the SafeBridge® program for "Potent Compound Safety Certification."
read more
Thursday, November 30, 2017
AMRI has more than doubled its current bulk API aseptic manufacturing capacity.
read more
AMRI will expand its nuclear magnetic resonance spectroscopy capabilities in Europe with the addition of the Bruker AVANCE NEO 600 MHz NMR Spectrometer.
read more
AMRI (NASDAQ: AMRI), a leading global contract research and manufacturing organization, announced today a key addition to the management team at its Singapore location. Saravanakumar Dhakshinamoorthy, Ph.D. joins AMRI’s Singapore site as Director of ...
read more